mandatory information Veno SL® 300
Veno SL® 300.
Active substance: Troxerutin. Therapeutic indications: Counteracting the formation of oedemas (oedema-protective agent), improving blood flow, providing supportive treatment of the accumulation of fluid in the tissue (exudative processes) and stabilising blood vessels that have become fine and fragile (capillary fragility). For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, www.ursapharm.de. Date of revision of the text: March 2019